Rajeev Singh
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Mosquito-borne diseases and control 13
-
- Viral Infections and Vectors 8
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Ramnath Misra (6 shared papers)Amita Aggarwal (4 shared papers)Michael S. Emery (1 shared paper)Toru Atsumi (4 shared papers)Masaya Harada (4 shared papers)Daisuke Kamimura (4 shared papers)Masaaki Murakami (4 shared papers)Hideki Ogura (4 shared papers)
- Journals
- Journal of Travel Medicine (2 papers)Lara D. Veeken (2 papers)Journal of Medical Virology (2 papers)Vector-Borne and Zoonotic Diseases (2 papers)Cell Reports (2 papers)
- Partner nations
- IndiaUnited KingdomUnited States
In The Last Decade
Rajeev Singh
53 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 118
- Hepatology 93
- Rheumatology 160
- Immunology 217
- Nephrology 70
- Cancer Research 97
Countries citing papers authored by Rajeev Singh
This map shows the geographic impact of Rajeev Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajeev Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajeev Singh more than expected).
Fields of papers citing papers by Rajeev Singh
This network shows the impact of papers produced by Rajeev Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajeev Singh. The network helps show where Rajeev Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside Rajeev Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 179 | |
| 2 | Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. | 2007 | 129 |
| 3 | 1995 | 80 | |
| 4 | 2013 | 79 | |
| 5 | Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. | 2004 | 78 |
| 6 | 2016 | 77 | |
| 7 | 2019 | 72 | |
| 8 | 2015 | 61 | |
| 9 | 2009 | 58 | |
| 10 | 2022 | 50 | |
| 11 | 2012 | 36 | |
| 12 | 2007 | 34 | |
| 13 | 2013 | 32 | |
| 14 | 2018 | 26 | |
| 15 | 2018 | 26 | |
| 16 | 2012 | 21 | |
| 17 | 2017 | 20 | |
| 18 | 2018 | 18 | |
| 19 | 2017 | 18 | |
| 20 | 2019 | 17 |
About Rajeev Singh
Rajeev Singh is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases, Molecular Biology, Parasitology and Surgery, having authored 62 papers that have together received 1.3k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (13 papers), Vector-borne infectious diseases (8 papers), Viral Infections and Vectors (8 papers), Spondyloarthritis Studies and Treatments (5 papers), CRISPR and Genetic Engineering (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Gout, Hyperuricemia, Uric Acid (2 papers). The work is most often cited by research in Hepatology (93 citations), Rheumatology (160 citations), Immunology (217 citations), Nephrology (70 citations) and Cancer Research (97 citations). Rajeev Singh has collaborated with scholars based in India, United Kingdom and United States. Frequent co-authors include Ramnath Misra, Amita Aggarwal, Michael S. Emery, Toru Atsumi, Masaya Harada, Daisuke Kamimura, Masaaki Murakami, Hideki Ogura, Jing‐Jing Jiang and Pooja Bhardwaj. Their work appears in journals such as Journal of Travel Medicine, Lara D. Veeken, Journal of Medical Virology, Vector-Borne and Zoonotic Diseases and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.